Baraniuk, James N · Fatigue : biomedicine, health & behavior · 2017 · DOI
This study compared two different sets of diagnostic criteria for ME/CFS by surveying a large representative sample of Americans. The researchers found that using the less strict Oxford criteria identified far more people as having ME/CFS (about 20-25%) compared to the stricter CDC (Fukuda) criteria (about 2%). When they looked more carefully at who truly had ME/CFS using both fatigue severity and other symptom requirements, they found that 85% of people labeled as CFS by the Oxford criteria didn't actually meet the stricter definition.
This study is crucial because it demonstrates that research findings from studies using less stringent diagnostic criteria may not apply to patients who meet stricter ME/CFS definitions. Many past treatment studies recruited participants using the permissive Oxford criteria, potentially leading to overestimated treatment benefits that don't reflect outcomes in people with more severe disease. Understanding which diagnostic criteria accurately identify true ME/CFS patients helps ensure that patients and clinicians can trust research results and clinical guidance.
This study does not definitively prove which diagnostic criteria are "correct" for ME/CFS, as it relies on questionnaire data rather than comprehensive clinical evaluation with objective biomarkers. It cannot establish causation or explain why Oxford criteria are more permissive; it only documents the prevalence difference. The study also does not evaluate how well either set of criteria predicts clinical outcomes or treatment response in real-world settings.